Article de revue

Analysis of safety data in children after receiving two doses of ProQuad® (MMRV)

Stephanie O. Klopfer, Jon E. Stek, Maria Petrecz, Keith S. Reisinger, Steven B. Black, Michelle G. Goveia, Ouzama Nicholson, Julie L. Gardner, Anthony D. Grosso, Michelle L. Brown, Barbara J. Kuter, Florian P. Schödel

In randomized clinical studies, over 11,800 children, 12 months to 6 years of age, were administered ProQuad®, a combination measles, mumps, rubella, and varicella vaccine (MMRV). This paper describes the safety following a 2-dose regimen of MMRV administered to children in the second year of life.

Auteurs

Langues

  • Anglais

Année de publication

2014

Journal

Vaccine

Volume

52

Type

Article de revue

Catégories

  • Vaccins et dispositifs d'administration

Maladies

  • Rougeole

Mots-clés

  • MAPI
  • Suivi de la couverture

Ajouté par: Moderator

Ajouté le: 2016-02-01 01:51:19

Consultations: 2186

Liens

Ajouter une ressource